These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36261067)

  • 1. From antioxidant to neuromodulator: The role of ascorbate in the management of major depression disorder.
    Ferreira NR; Vitorino C; Fortuna A
    Biochem Pharmacol; 2022 Dec; 206():115300. PubMed ID: 36261067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressants for the treatment of depression in people with cancer.
    Ostuzzi G; Matcham F; Dauchy S; Barbui C; Hotopf M
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011006. PubMed ID: 26029972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of atypical antipsychotics in depressive syndromes].
    Quintin P; Thomas P
    Encephale; 2004; 30(6):583-9. PubMed ID: 15738862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of an adjuvant antidepressant on the efficacy of electroconvulsive therapy: A systematic review and meta-analysis.
    Pluijms EM; Kamperman AM; Hoogendijk WJ; Birkenhäger TK; van den Broek WW
    Aust N Z J Psychiatry; 2021 Apr; 55(4):366-380. PubMed ID: 32900217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials.
    Huang KL; Lu WC; Wang YY; Hu GC; Lu CH; Lee WY; Hsu CC
    Aust N Z J Psychiatry; 2014 Jul; 48(7):663-71. PubMed ID: 24604920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Other Antidepressants.
    Schwasinger-Schmidt TE; Macaluso M
    Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agomelatine versus other antidepressive agents for major depression.
    Guaiana G; Gupta S; Chiodo D; Davies SJ; Haederle K; Koesters M
    Cochrane Database Syst Rev; 2013 Dec; 2013(12):CD008851. PubMed ID: 24343836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents.
    Papakostas GI; Thase ME; Fava M; Nelson JC; Shelton RC
    Biol Psychiatry; 2007 Dec; 62(11):1217-27. PubMed ID: 17588546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multinational pharmacoeconomic evaluation of acute major depressive disorder (MDD): a comparison of cost-effectiveness between venlafaxine, SSRIs and TCAs.
    Doyle JJ; Casciano J; Arikian S; Tarride JE; Gonzalez MA; Casciano R
    Value Health; 2001; 4(1):16-31. PubMed ID: 11704969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoamine neurocircuitry in depression and strategies for new treatments.
    Hamon M; Blier P
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive review on the efficacy of S-Adenosyl-L-methionine in Major Depressive Disorder.
    De Berardis D; Orsolini L; Serroni N; Girinelli G; Iasevoli F; Tomasetti C; de Bartolomeis A; Mazza M; Valchera A; Fornaro M; Perna G; Piersanti M; Di Nicola M; Cavuto M; Martinotti G; Di Giannantonio M
    CNS Neurol Disord Drug Targets; 2016; 15(1):35-44. PubMed ID: 26295824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
    Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of cognitive impairment between medicated and medication-free patients with remitted major depression: class-specific influence by tricyclic antidepressants and newer antidepressants.
    Nagane A; Baba H; Nakano Y; Maeshima H; Hukatsu M; Ozawa K; Suzuki T; Arai H
    Psychiatry Res; 2014 Aug; 218(1-2):101-5. PubMed ID: 24768252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A brief history of the development of antidepressant drugs: from monoamines to glutamate.
    Hillhouse TM; Porter JH
    Exp Clin Psychopharmacol; 2015 Feb; 23(1):1-21. PubMed ID: 25643025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vortioxetine for depression in adults.
    Koesters M; Ostuzzi G; Guaiana G; Breilmann J; Barbui C
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011520. PubMed ID: 28677828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Edivoxetine compared to placebo as adjunctive therapy to selective serotonin reuptake inhibitors in the prevention of symptom re-emergence in major depressive disorder.
    Oakes TM; Dellva MA; Waterman K; Greenbaum M; Poppe C; Goldberger C; Ahl J; Perahia DG
    Curr Med Res Opin; 2015 Jun; 31(6):1179-89. PubMed ID: 25894953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal markers of therapeutic responses in major depressive disorder: Effects of antidepressants on retinal function.
    Moulard M; Cosker E; Angioi-Duprez K; Laprévote V; Schwan R; Schwitzer T
    J Psychiatr Res; 2022 Oct; 154():71-79. PubMed ID: 35932524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New approaches to developing antidepressants by enhancing monoaminergic neurotransmission.
    Bymaster FP; McNamara RK; Tran PV
    Expert Opin Investig Drugs; 2003 Apr; 12(4):531-43. PubMed ID: 12665410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-line pharmacotherapies for depression - what is the best choice?
    Koenig AM; Thase ME
    Pol Arch Med Wewn; 2009; 119(7-8):478-86. PubMed ID: 19776688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tricyclic Antidepressants and Monoamine Oxidase Inhibitors: Are They Too Old for a New Look?
    Chockalingam R; Gott BM; Conway CR
    Handb Exp Pharmacol; 2019; 250():37-48. PubMed ID: 30105472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.